✦ LIBER ✦

Pharmacological management of type 2 diabetes: the potential of incretin-based therapies

✍ Scribed by B. Charbonnel; B. Cariou

Book ID: 109045072
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 707 KB
Volume: 13
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2010.01317.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The evolving place of incretin-based the

The evolving place of incretin-based therapies in type 2 diabetes

✍ Baptist Gallwitz 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 281 KB

Diabetes and Cardiovascular Disease: The

Diabetes and Cardiovascular Disease: The Potential Benefit of Incretin-Based Therapies

✍ Daniel Addison; David Aguilar 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 163 KB

Emerging role of insulin with incretin t

Emerging role of insulin with incretin therapies for management of type 2 diabetes

✍ Rupa Ahluwalia; Jiten Vora 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 639 KB

New treatments in type 2 diabetes: a foc

New treatments in type 2 diabetes: a focus on the incretin-based therapies

✍ Anthony H. Barnett 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

Management of type 2 diabetes: the role

Management of type 2 diabetes: the role of incretin mimetics

✍ John H. Holcombe; Dennis D. Kim; Anthony H. Stonehouse; David M. Kendall 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract Current strategies for the treatment of type 2 diabetes target deficient insulin secretion and insulin resistance, but have not been shown to correct the progressive β–cell dysfunction characteristic of the disease. Traditionally, type 2 diabetes is treated in a stepwise manner with med

The physiology and pharmacology of incre

The physiology and pharmacology of incretins in type 2 diabetes mellitus

✍ Jens J. Holst 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB